Thus, the heme degradation products, CO and bilirubin, synergistically enforce metabolic reprogramming in the process of recovery following ischemic brain injury by increasing glycolytic activity, mitochondrial biogenesis, and angiogenesis via the HIF-1α/ERRα axis. Here, HIF1A is linked to injury.